Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
- 23 October 2003
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 186 (2) , 158-172
- https://doi.org/10.1016/s0014-4886(03)00342-x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Characterization of Cytoplasmic α-Synuclein AggregatesJournal of Biological Chemistry, 2002
- Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived MembranesBiochemistry, 2002
- Prostate Apoptosis Response‐4 Production in Synaptic Compartments Following Apoptotic and Excitotoxic InsultsJournal of Neurochemistry, 1999
- Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filamentsFEBS Letters, 1998
- Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease MutationJournal of Biological Chemistry, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Glutamate Receptor Binding Sites in MPTP-Treated MiceExperimental Neurology, 1993
- Neuropathologic Features of Parkinson's, Huntington's, and Alzheimer's DiseasesaAnnals of the New York Academy of Sciences, 1992